Clinical Trials Browser

Phase 2 × INDUSTRY × Prostatic Hyperplasia × Clear all

NCT04693507 2024-07-23

TEACh

Phase 2 Completed

50 enrolled 43 charts

Prostatic Hyperplasia

NCT01194960 2020-10-19

TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)

Phase 2 Terminated

Prostatic Hyperplasia, Prostatic Neoplasms